RE:Grail only 18% Stage 1 and 43% Stage 2
LithLover wrote: I recently saw someone on CEO. ca talking about Grail. I mean come on they are less than 50% detecting cancers up to Stage 2 and yet look at their market value and all the marketing and hype they get.
18% at Stage 1 and 43% for Stage 1 and 2. Come on.
Stagezero's (detecting cancers at Stage 0) time will come.
https://www.oncodna.com/en/company/activity/news-list/cancer-screening-early-detection-a-methylation-based-ctdna-assay-from-grail-delivered-sensitivity-93-for-stage-iv-cancer-falling-to-43-for-stage-ii-and-18-for-stage-i-disease/
Again it prove's that shareprice is driven by the demand and supply of it's shares....no mater what the fundamental is saying.
Look at Gamestop market valuation and what the fundamental is worthed....an insane market cap because of demand for that stock during short squeeze made them a high evaluation market cap.
One day SZLS will do the same, once's investors will want shares of SZLS in their portofolio and the supply wouldn't be able to sustain the demand, shareprice will increase.
And one last thing, you will notice basher will use the shareprice as an indicator of how a company is doing....which is a non-sense as shareprice and day to day bussiness is 2 different things. They both have demand and supply market but one is about shares and the other is about products/services.
At the end, is theses test saves life, the company have succeeded on their mission. After that, the rest will follow...
have a great weekend!